Effects of the Overexpression of Progesterone Receptors on a Precancer p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line

Int J Mol Sci. 2023 Jul 23;24(14):11823. doi: 10.3390/ijms241411823.

Abstract

This study investigated the effects of progesterone receptors A (PRA) and B (PRB) on proliferation, migration, invasion, anchorage-independent growth (AIG), and apoptosis of FE25 cells, a precancer p53- and retinoblastoma-defective human fallopian tube epithelial cell line. We observed that the transfection of PRA (FE25-PRA) or PRB (FE25-PRB) into FE25 cells significantly increased the expression of PRA or PRB at both RNA and protein levels without affecting cell morphology. The FE25-PRA cells exhibited slower proliferation, whereas FE25-PRB showed faster cell proliferation than the control cells. In contrast, the FE25-PRA cells showed the highest migration and invasion abilities, whereas the FE25-PRB cells showed the lowest migration and invasion abilities. After treatment with progesterone, all cell types showed decreased AIG levels, increased apoptotic rates in Terminal deoxynucleotidyl transferase (TdT) dUTP nick end labeling assay (TUNEL) staining, and increased levels of apoptotic proteins ascertained based on cleaved caspase-3 levels. The half-maximal inhibitory concentration of carboplatin increased in FE25-PRB cells, but that of paclitaxel remained unchanged. Overall, this study suggests that PRA and PRB have distinct roles in regulating the behavior of FE25 cells, and targeting these receptors could be a potential therapeutic strategy for ovarian cancer treatment. If PRA or PRB overexpression is observed in high-grade serous carcinoma, progesterone could be considered as an adjuvant therapy for these specific cancer patients. However, further research is needed to confirm these findings and investigate the mechanisms underlying these effects.

Keywords: FE25; fallopian tube epithelial cells; p53; progesterone receptors; retinoblastoma.

MeSH terms

  • Cell Line, Tumor
  • Epithelial Cells / metabolism
  • Fallopian Tubes / metabolism
  • Female
  • Humans
  • Progesterone* / pharmacology
  • Receptors, Progesterone* / genetics
  • Receptors, Progesterone* / metabolism
  • Retinoblastoma Protein
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Progesterone
  • Receptors, Progesterone
  • Tumor Suppressor Protein p53
  • TP53 protein, human
  • Retinoblastoma Protein